BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 37090372)

  • 1. Systemic Inflammatory Response Syndrome After Extracorporeal Membrane Oxygenation Decannulation in COVID-19 Patients.
    Kirupaharan P; Blazoski C; Hilton R; Feduska E; Leong R; Baram M
    Cureus; 2023 Mar; 15(3):e36436. PubMed ID: 37090372
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systemic inflammatory response syndrome (SIRS) after extracorporeal membrane oxygenation (ECMO): Incidence, risks and survivals.
    Thangappan K; Cavarocchi NC; Baram M; Thoma B; Hirose H
    Heart Lung; 2016; 45(5):449-53. PubMed ID: 27425197
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence of healthcare-associated infections in patients with fever during the first 48 hours after decannulation from veno-venous extracorporeal membrane oxygenation.
    Esposito EC; Jones KM; Galvagno SM; Kaczorowski DJ; Mazzeffi MA; DiChiacchio L; Deatrick KB; Madathil RJ; Herrold JA; Rabinowitz RP; Scalea TM; Menaker J
    Perfusion; 2021 May; 36(4):421-428. PubMed ID: 32820708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cause of In-Hospital Death After Weaning from Venoarterial-Extracorporeal Membrane Oxygenation.
    Bjelic M; Kumar N; Gu Y; Chase K; Paic F; Gosev I
    J Intensive Care Med; 2022 Dec; 37(12):1545-1552. PubMed ID: 35285729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcomes of extracorporeal membrane oxygenation in immunosuppressed vs. Immunocompetent patients.
    Blazoski C; Kirupaharan P; Hilton R; Leong R; Baram M
    Heart Lung; 2023; 58():179-184. PubMed ID: 36535131
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association Between Body Mass Index and Outcomes in Venoarterial Extracorporeal Membrane Oxygenation.
    Lu SY; Ortoleva J; Colon K; Mueller A; Laflam A; Shelton K; Dalia AA
    Anesth Analg; 2022 Feb; 134(2):341-347. PubMed ID: 34881861
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Delaying Decannulation After Extracorporeal Membrane Oxygenation Is Safe and Advantageous.
    Thompson JL; Griffeth E; Rappa N; Calame C; Letton RW; Burkhart HM
    World J Pediatr Congenit Heart Surg; 2019 Jan; 10(1):98-100. PubMed ID: 30799706
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nucleated red blood cells as a biomarker for mortality in infants and neonates requiring veno-arterial extracorporeal membrane oxygenation for cardiac disease.
    Piggott KD; Norlin C; Laviolette C; Turner J; Lewis L; Soliman A; Hebert D; Pettitt T
    Perfusion; 2023 Mar; 38(2):299-304. PubMed ID: 34636269
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.
    Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S
    Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Common carotid artery imaging after vessel sparing decannulation from Extracorporeal Membrane Oxygenation (ECMO) support.
    Carpenter JL; Baker M; Sperberg K; Berger JT; Vezina G; Sinha P
    J Pediatr Surg; 2021 Dec; 56(12):2305-2310. PubMed ID: 33632514
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcomes of end-organ function and survival with veno-arterial extracorporeal membrane oxygenation.
    Mihama T; Bahatyrevich N; Cavarocchi N; Hirose H
    Perfusion; 2021 Nov; 36(8):808-813. PubMed ID: 33198559
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Echocardiographic Assessment of Biventricular Function in 249 Patients During the Peri-Extracorporeal Membrane Oxygenation Period.
    Ortoleva JP; Dalia AA; Fiedler AG; D'Alessandro D; Shelton K; Villavicencio M; Cudemus GA
    J Cardiothorac Vasc Anesth; 2019 May; 33(5):1325-1330. PubMed ID: 30482702
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extracorporeal membrane oxygenation in COVID-19 compared to other etiologies of acute respiratory failure: A single-center experience.
    Yaqoob H; Greenberg D; Huang L; Henson T; Pitaktong A; Peneyra D; Spencer PJ; Malekan R; Goldberg JB; Kai M; Ohira S; Wang Z; Murad MH; Chandy D; Epelbaum O
    Heart Lung; 2023; 57():243-249. PubMed ID: 36274533
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of Respiratory Parameters at Venovenous Extracorporeal Membrane Oxygenation Liberation With Duration of Mechanical Ventilation and ICU Length of Stay: A Prospective Cohort Study.
    Thiara S; Serpa Neto A; Burrell AJC; Fulcher BJ; Hodgson CL
    Crit Care Explor; 2022 May; 4(5):e0689. PubMed ID: 35517643
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of Extracorporeal Membrane Oxygenation Support for Single Ventricle Patients.
    Stephens EH; Shakoor A; Jacobs SE; Okochi S; Zenilman AL; Middlesworth W; Kalfa D; Chai PJ; Chaves DV; Bacha E; Cheung EW
    World J Pediatr Congenit Heart Surg; 2020 Mar; 11(2):183-191. PubMed ID: 32093561
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcomes of extracorporeal membrane oxygenation in influenza versus COVID-19 during the first wave of COVID-19.
    Blazoski CM; Baram M; Yang Q; Hirose H
    J Card Surg; 2021 Oct; 36(10):3740-3746. PubMed ID: 34369601
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Phase I/II Clinical Trial to evaluate the efficacy of baricitinib to prevent respiratory insufficiency progression in onco-hematological patients affected with COVID19: A structured summary of a study protocol for a randomised controlled trial.
    Moreno-González G; Mussetti A; Albasanz-Puig A; Salvador I; Sureda A; Gudiol C; Salazar R; Marin M; Garcia M; Navarro V; de la Haba Vaca I; Coma E; Sanz-Linares G; Dura X; Fontanals S; Serrano G; Cruz C; Mañez R
    Trials; 2021 Feb; 22(1):116. PubMed ID: 33546739
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk Factors of Mortality for Patients Receiving Venovenous Extracorporeal Membrane Oxygenation for COVID-19 Acute Respiratory Distress Syndrome.
    Bergman ZR; Wothe JK; Alwan FS; Lofrano AE; Tointon KM; Doucette M; Bohman JK; Saavedra-Romero R; Prekker ME; Lusczek ER; Beilman G; Brunsvold ME
    Surg Infect (Larchmt); 2021 Dec; 22(10):1086-1092. PubMed ID: 34494893
    [No Abstract]   [Full Text] [Related]  

  • 20. Implementation of new ECMO centers during the COVID-19 pandemic: experience and results from the Middle East and India.
    Rabie AA; Azzam MH; Al-Fares AA; Abdelbary A; Mufti HN; Hassan IF; Chakraborty A; Oza P; Elhazmi A; Alfoudri H; Pooboni SK; Alharthy A; Brodie D; Zakhary B; Shekar K; Antonini MV; Barrett NA; Peek G; Combes A; Arabi YM
    Intensive Care Med; 2021 Aug; 47(8):887-895. PubMed ID: 34156477
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.